Mitrovic is involved in multiple national and international clinical drug and device trials in heart failure and arrhythmia. Veselin Mitrovic, MD, is a Professor of Cardiology at the Johann-Wolfgang Goethe University in Frankfurt-on-Main, Germany, and Medical Director of Kerckhoff-Klinik Forschungsgesellschaft mbH, and a senior consultant at Kerckhoff-Klinik GmbH in Bad Nauheim, Germany. Anker is the founding Editor-in-Chief of the ESC Heart Failure journal. He has served on the Board of the Heart Failure Association of the European Society of Cardiology (ESC) since 2006 and was HFA President from 2012-2014. Anker has won several prizes, including the 2018 Copernicus Prize of German DFG and Polish FNP. Stefan Anker, MD, Ph.D., is a Professor of (Tissue) Homeostasis in Cardiology & Metabolism at Charité University in Berlin and has authored more than 950 original papers, reviews and editorials.
Serving on several peer-review journal editorial boards, he has extensive clinical trial experience and has published over 600 peer-reviewed scientific papers. Butler is board certified in Cardiovascular Medicine, Advanced Heart Failure and Transplant Medicine.
Lehan Chair in Cardiovascular Research, Professor and Chairman in the Department of Medicine, and Professor of Physiology at the University of Mississippi Medical Center. Javed Butler, MD, MPH, MBA, is the Patrick H. “It’s an honor to join the Heart Failure Advisory Board and be appointed its chairman to guide ushering in new clinical developments.” FAST’s technology could be transformative in this space,” said Zelenkofske. “Heart failure is a common diagnosis, but with a common challenge: accurately assessing patients’ fluid status to determine treatment. Zelenkofske was previously CMO of Achillion Pharmaceuticals and Regado Biosciences and held senior leadership positions at Astra-Zeneca, Sanofi-Aventis, Boston Scientific and Novartis. He has led teams to regulatory approvals worldwide and led or participated in over a dozen NCE and sNDA approvals. Zelenkofske is currently Chief Medical Officer for SwanBio Therapeutics. With over 20 years of industry experience bringing cardiovascular products through clinical development, Dr. Steven Zelenkofske, D.O., M.S., FACC, FCCP, FACOI, has been appointed Chairman of the Heart Failure Medical Advisory Board. The board collectively has decades of experience in heart failure and cardiovascular patient care and have contributed to more than 1,300 peer-reviewed publications. The Board will advise FAST’s clinical development of measuring volume status to better treat heart failure patients. 17, 2020 /PRNewswire/ - FAST BioMedical, a late clinical-stage medical technology company, today announces establishing a Heart Failure Medical Advisory Board of world-recognized physicians, nurses and researchers.